Carmell Therapeutics Corporation (CTCX) — Financial Flexibility Index
Carmell Therapeutics Corporation (CTCX) has a Financial Flexibility Index of -0.11x as of March 2025. Free cash flow of $-752.95K (operating CF $-752.95K minus capex $0.00) represents 0% of total liabilities ($7.14 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Carmell Therapeutics Corporation Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Carmell Therapeutics Corporation across 4 annual periods. See working capital position of Carmell Therapeutics Corporation to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Carmell Therapeutics Corporation (2021–2024)
Year-by-year free cash flow to debt coverage for Carmell Therapeutics Corporation. For the full company profile including market capitalisation, see how much is Carmell Therapeutics Corporation worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.71x | $-4.39 Million | $-4.39 Million | $6.19 Million | ▼ -234.3% |
| 2023 | -0.21x | $-8.32 Million | $-8.35 Million | $39.20 Million | ▼ -145.2% |
| 2022 | -0.09x | $-3.42 Million | $-3.43 Million | $39.54 Million | ▼ -130.4% |
| 2021 | -0.04x | $-1.17 Million | $-1.18 Million | $31.13 Million | — |